BSX vs CHYM · P/E 20, rev $10.65B vs rev $2.19B
Boston Scientific Corp (BSX) versus Chime Financial, Inc. Class A Common Stock (CHYM) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Chime Financial, Inc. Class A Common Stock (CHYM) is a software - application company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CHYM revenue for 2025-12-31 was $2.19B. Net income was -$1.01B. Revenue was up 30.7% from 2024-12-31 to 2025-12-31. CHYM currently screens at market cap $11.53B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CHYM currently screens at market cap $11.53B.
Not investment advice. Open the BSX and CHYM stock pages for the full models.
Not investment advice.